Huiran Yue
No.419, Fangxie Road
Shanghai, 200011, China
Shanghai, 200011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
S100B induces angiogenesis via the clathrin/FOXO1/β-catenin signaling pathway and contributes to Bevacizumab resistance in epithelial ovarian cancer.
Journal: Journal of advanced research
Published: February 15, 2025
Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance.
Journal: Acta biochimica et biophysica Sinica
Published: April 06, 2023
The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer.
Journal: Journal of translational medicine
Published: September 08, 2022
Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression.
Journal: Journal of ovarian research
Published: September 29, 2021
DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer.
Journal: Clinical epigenetics
Published: February 21, 2021
Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
Journal: Gynecologic oncology
Published: August 06, 2020
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
Journal: BMC cancer
Published: February 08, 2020
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer.
Journal: BMC cancer
Published: October 01, 2019
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer.
Journal: Cancer cell international
Published: September 10, 2019
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer.
Journal: Journal of ovarian research
Published: March 28, 2019
Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: March 26, 2019
SNAI2 3'untranslated region promotes the invasion of ovarian cancer cells by inducing MARCKS expression.
Journal: Journal of Cancer
Published: August 26, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026